about
Review of tumor dormancy therapy using traditional oriental herbal medicineThe multifaceted roles of autophagy in tumors-implications for breast cancer.Transcriptional changes induced by the tumor dormancy-associated microRNA-190Microenvironmental regulation of metastasisGlobal dormancy of metastases due to systemic inhibition of angiogenesisTamoxifen induces pleiotrophic changes in mammary stroma resulting in extracellular matrix that suppresses transformed phenotypesDetection of Lysyl Oxidase-Like 2 (LOXL2), a Biomarker of Metastasis from Breast Cancers Using Human Blood Samples.A signature of epithelial-mesenchymal plasticity and stromal activation in primary tumor modulates late recurrence in breast cancer independent of disease subtype.Consensus micro RNAs governing the switch of dormant tumors to the fast-growing angiogenic phenotype.Prospective identification of glioblastoma cells generating dormant tumors.Computational design of a CNT carrier for a high affinity bispecific anti-HER2 antibody based on trastuzumab and pertuzumab Fabs.Basement membrane-rich organoids with functional human blood vessels are permissive niches for human breast cancer metastasis.Antimitotic chemotherapeutics promote adhesive responses in detached and circulating tumor cellsLuminal breast cancer metastases and tumor arousal from dormancy are promoted by direct actions of estradiol and progesterone on the malignant cellsROCK inhibition activates MCF-7 cellsControversies in clinical cancer dormancyBreast cancer stem cells survive periods of farnesyl-transferase inhibitor-induced dormancy by undergoing autophagy.Integrin α3β1 as a breast cancer targetExcision of the primary tumour in patients with metastatic breast cancer: a clinical dilemmaER, PR, HER2, Ki-67 and CK5 in Early and Late Relapsing Breast Cancer-Reduced CK5 Expression in Metastases.Estrogen Receptor Status Predicts Late-Onset Skeletal Recurrence in Breast Cancer PatientsLoss of Raf kinase inhibitory protein induces radioresistance in prostate cancer.Imaging Sensitivity of Quiescent Cancer Cells to Metabolic Perturbations in Bone Marrow SpheroidsPrimary and metastatic tumor dormancy as a result of population heterogeneity.Integrins in mammary-stem-cell biology and breast-cancer progression--a role in cancer stem cells?BMI1 cooperates with H-RAS to induce an aggressive breast cancer phenotype with brain metastases.Platelet proteome and tumor dormancy: can platelets content serve as predictive biomarkers for exit of tumors from dormancy?Angiopoietin-2 promotes ER+ breast cancer cell survival in bone marrow niche.Micrometastatic disease and metastatic outgrowth: clinical issues and experimental approaches.The dormancy dilemma: quiescence versus balanced proliferation.Local expression of interleukin-2 by B16 melanoma cells results in decreased tumour growth and long-term tumour dormancy.Nontoxic, fiscally responsible, future of oncology: could it be beginning in the Third World?Tumor dormancy and frailty models: A novel approach.Increased risk of recurrence associated with certain risk factors in breast cancer patients after DIEP-flap reconstruction and lipofilling-a matched cohort study with 200 patients.Oxidative and nitrosative stress in the metastatic microenvironment.Invasive lobular and ductal breast carcinoma differ in immune response, protein translation efficiency and metabolism.Aloperine inhibits proliferation, migration and invasion and induces apoptosis by blocking the Ras signaling pathway in human breast cancer cells
P2860
Q27025327-A22F1A21-A54F-4551-B05A-0A0D8483CE93Q27692102-CFFD16EA-3C1C-42B4-95A1-C8D1213AA1DCQ28383492-94CFE882-1D88-4BFA-BA26-40F47058CD98Q29547660-51755C9B-D19E-4B6F-82FC-77DA7D5CA9B9Q31148727-0E3FDB91-31B2-4DD3-A151-1E24CC45F54EQ33403396-87282733-B289-47D8-98CE-7667FE7EEA91Q33859309-366CB571-32EF-4264-9730-DBBDCACFFBB4Q34296481-886B1A09-FF6C-4703-889F-2D7F3738D3BFQ34406041-BA518FDF-0E11-4992-A8BA-F470A9F03B27Q34412360-6B8230C2-FCE7-48F1-A2AB-BD0866615267Q34473476-5606B9CC-86C5-467F-99CC-2BFAECFD7E3DQ34951833-91C457C5-E5F1-4FEA-9489-1C70997F1CFEQ34991861-D9C95685-0C67-4F58-A695-35C184BC727AQ35000639-048D5EA1-5B5A-4BB9-86C1-F2019306EFC2Q35093634-C571FCFB-8F5E-4608-B8CF-D76970904BF5Q35134139-80219FF7-2AEA-43A6-813E-24032077B286Q35429053-FBB96B1A-2ED6-4E78-B6E0-A015EF03806BQ35539262-2852F6CB-2BAF-436B-8807-A49D95A3D3FFQ36136889-E097C7CA-4F48-4DF2-894D-1EDAAAB05386Q36629859-B5E83DFE-6ECB-4921-A61C-9DEC1BF6F55FQ36653686-CF4CB572-7C9F-432E-BE7F-8F89421DA822Q37001604-9DC9FF0F-30E6-44DD-91AF-93B86C30C7E6Q37130950-44070DD2-5002-4D4B-8755-B15D600DEB21Q37196014-20941BAC-BBED-44DC-9CD8-7E4D164FFDFEQ37271589-8D9CDDBA-65B5-426F-AAF5-B29729711EA5Q37323642-0B773191-BB12-4BD6-BA2F-CD4A9D477B35Q37328356-770DBC71-AD7A-45C3-806E-561C85FFC6F1Q37340509-B4245304-74E6-4F34-BAC4-76BCC2987A78Q37605872-F1F3A760-EE9A-4F14-ABCD-4593696B353EQ38116507-89467338-D742-4B0D-A9D7-124C15FB45F2Q39235364-9EE78F33-A725-4074-8C93-2DCE20B7F43BQ39804633-2BD809B4-01FF-4C80-8FFF-8AE6928F81AAQ40658582-32B488BE-47A5-425F-ABCF-DC0AB14DB4E1Q41485550-1368C81B-5854-4CD8-81D2-86FADCA8FDA8Q42875853-3F0EAE93-977A-4F5F-BF49-8F222B6BC97BQ55396783-3EEF0AB9-C85B-4910-8059-AC1931EAB46CQ58718317-644636D0-FBDB-4DBD-87D9-5162850ED4F9
P2860
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Tumour dormancy in breast cancer: an update
@ast
Tumour dormancy in breast cancer: an update
@en
type
label
Tumour dormancy in breast cancer: an update
@ast
Tumour dormancy in breast cancer: an update
@en
prefLabel
Tumour dormancy in breast cancer: an update
@ast
Tumour dormancy in breast cancer: an update
@en
P2093
P2860
P356
P1476
Tumour dormancy in breast cancer: an update
@en
P2093
Ann F Chambers
Jason L Townson
Muriel Brackstone
P2860
P2888
P356
10.1186/BCR1677
P577
2007-01-01T00:00:00Z
P5875
P6179
1027972004